These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

914 related items for PubMed ID: 24647156

  • 1. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J, Wang W, Wang H, Liu X, Guo X.
    Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
    [Abstract] [Full Text] [Related]

  • 2. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo.
    Zhang P, Zheng BB, Wang HY, Chen JH, Liu XY, Guo XL.
    J Pharm Pharmacol; 2014 Mar; 66(3):398-407. PubMed ID: 24533823
    [Abstract] [Full Text] [Related]

  • 3. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
    Song YN, Guo XL, Zheng BB, Liu XY, Dong X, Yu LG, Cheng YN.
    Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
    [Abstract] [Full Text] [Related]

  • 4. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R, Shao F, Liu Z, Zhang J, Wang S, Liu J, Liu H, Chen H, Liu K, Xia M, Wang Y.
    Chem Biol Interact; 2013 Sep 05; 205(1):1-10. PubMed ID: 23777986
    [Abstract] [Full Text] [Related]

  • 5. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM, Kim SR, Hong SH, Choi HS, Seo HS, Shin YC, Ko SG.
    Mol Cell Biochem; 2015 Nov 05; 409(1-2):33-43. PubMed ID: 26169986
    [Abstract] [Full Text] [Related]

  • 6. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
    Huang Q, Wu YY, Xing SJ, Yu ZW.
    Eur Rev Med Pharmacol Sci; 2019 Jun 05; 23(12):5285-5292. PubMed ID: 31298380
    [Abstract] [Full Text] [Related]

  • 7. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
    Zhang D, Zhang Q, Zheng Y, Lu J.
    J Ethnopharmacol; 2020 Sep 15; 259():112984. PubMed ID: 32446927
    [Abstract] [Full Text] [Related]

  • 8. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
    Zhao Y, Wang X, Sun Y, Zhou Y, Yin Y, Ding Y, Li Z, Guo Q, Lu N.
    Apoptosis; 2015 Sep 15; 20(9):1253-69. PubMed ID: 26153346
    [Abstract] [Full Text] [Related]

  • 9. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
    Xu Y, Fang R, Shao J, Cai Z.
    Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34036307
    [Abstract] [Full Text] [Related]

  • 10. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
    Ren J, Xu Y, Huang Q, Yang J, Yang M, Hu K, Wei K.
    Anticancer Drugs; 2015 Jun 25; 26(5):498-507. PubMed ID: 25714087
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R, Li K, Yuan DW, Wang HN, Zhang Y, Dang CX, Zhu K.
    Int J Oncol; 2018 Dec 25; 53(6):2566-2578. PubMed ID: 30320337
    [Abstract] [Full Text] [Related]

  • 12. The synergistic effect of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside combined with Adriamycin on MCF-7 breast cancer cells.
    Shen J, Zhang Y, Shen H, Pan H, Xu L, Yuan L, Ding Z.
    Drug Des Devel Ther; 2018 Dec 25; 12():4083-4094. PubMed ID: 30555223
    [Abstract] [Full Text] [Related]

  • 13. PDB-1 from Potentilla discolor Bunge induces apoptosis and autophagy by downregulating the PI3K/Akt/mTOR signaling pathway in A549 cells.
    Zhang RR, Meng NN, Liu C, Li KL, Wang MX, Lv ZB, Chen SY, Guo X, Wang XK, Wang Q, Sun JY.
    Biomed Pharmacother; 2020 Sep 25; 129():110378. PubMed ID: 32544818
    [Abstract] [Full Text] [Related]

  • 14. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 25; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 15. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov 25; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H, Li L, Yang S, Wang D, Zhong S, Zhao J, Tang J.
    Gene; 2016 Nov 15; 593(1):84-90. PubMed ID: 27523474
    [Abstract] [Full Text] [Related]

  • 17. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
    Li Y, Zhai Z, Li H, Wang X, Huang Y, Su X.
    Chem Biol Interact; 2019 May 25; 305():98-104. PubMed ID: 30929998
    [Abstract] [Full Text] [Related]

  • 18. Paris saponin VII enhanced the sensitivity of HepG2/ADR cells to ADR via modulation of PI3K/AKT/MAPK signaling pathway.
    Tang GE, Niu YX, Li Y, Wu CY, Wang XY, Zhang J.
    Kaohsiung J Med Sci; 2020 Feb 25; 36(2):98-106. PubMed ID: 31688993
    [Abstract] [Full Text] [Related]

  • 19. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J, Zuo D, Qi H, Shen Q, Bai Z, Han M, Li Z, Zhang W, Wu Y.
    Biomed Pharmacother; 2016 Mar 25; 78():308-321. PubMed ID: 26898456
    [Abstract] [Full Text] [Related]

  • 20. Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin.
    He Y, Ding J, Lin Y, Li J, Shi Y, Wang J, Zhu Y, Wang K, Hu X.
    BMC Complement Altern Med; 2015 Jun 12; 15():181. PubMed ID: 26066793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.